Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Predicted Market Size Of The Gut Microbiota Industry By 2029?

The market size of gut microbiota has witnessed a rapid acceleration in growth in the past few years. The market is expected to expand from $0.55 billion in 2024 to $0.65 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 17.9%. This notable growth during the historic period is largely due to several factors including the discovery of pro and prebiotics, an increase in gastrointestinal disorders, a heightened interest in functional foods, the escalating usage of antibiotics, and enhanced awareness regarding the gut-brain axis.

In the coming years, the gut microbiota market is predicted to experience a significant expansion. The market size will escalate to $1.25 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 17.9%. This projected growth during the forecast period can be linked to the broadening of personalized nutrition, increasing need for microbiome-related therapeutics, development in functional and fermented foods, and official backing for both probiotics and prebiotics. Predominant trends for the forecast period encompass the use of Artificial Intelligence (AI) for microbiome assessment, advancements in next-generation sequencing, gut microbiota tweaking with CRISPR, advancement of intelligent probiotic delivery mechanisms, and the use of wearable devices for monitoring gut health.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23411&type=smp

Which Industry Forces Are Driving The Gut Microbiota Market Forward?

As personalized healthcare gains traction, it is anticipated to fuel the expansion of the gut microbiota market. Personalized healthcare customizes treatment plans based on a patient’s genetic makeup, environment and lifestyle factors to deliver optimal results and enhanced patient care. As advancements in genomics and biotech make it possible to pinpoint genetic profiles with increased accuracy, demand grows for personalized healthcare that allows for tailor-made treatments to enhance efficacy and limit side effects. With regard to gut microbiota, personalized healthcare optimizes gut health by customizing treatments based on an individual’s unique microbiome composition, thus enhancing outcomes for digestive and metabolic disorders. For instance, the U.S Food and Drug Administration (FDA), as reported by the Personalized Medicine Coalition (PMC), a non-profit organization based in the U.S, approved 26 new personalized medicines in 2023, a notable increase from the 12 approved in 2022. Consequently, the escalating demand for personalized healthcare is facilitating the growth of the gut microbiota market.

What Is The Segment Breakdown Of The Gut Microbiota Market?

The gut microbiotamarket covered in this report is segmented –

1) By Product: Prebiotics; Probiotics; Drugs; Supplements; Other Products

2) By Application: Digestive Health; Immune Health; Weight Management; Mental Health; Cardiovascular Health

3) By Distribution Channel: Pharmacies And Drugstores; Online Retail; Health Food Stores; Supermarkets And Hypermarkets; Specialty Stores

4) By End-Users: Adults; Children; Elderly

Subsegments:

1) By Prebiotics: Fructooligosaccharides (Fos); Galactooligosaccharides (Gos); Inulin; Resistant Starch; Beta-Glucans; Arabinogalactans; Pectins

2) By Probiotics: Lactobacillus; Bifidobacterium; Saccharomyces; Streptococcus; Bacillus; Escherichia

3) By Drugs: Antibiotics; Bacteriophage Therapy; Gut Microbiota Modulators; Immunomodulators; Antidiarrheal Agents; Laxatives

4) By Supplements: Synbiotics; Postbiotics; Enzyme Supplements; Vitamin D Supplements; Omega-3 Fatty Acids; Herbal Extracts

5) By Other Products: Functional Foods; Fermented Foods; Beverages; Gut Health Diagnostic Kits; Dietary Fiber Products

What Are The Dominant Trends Currently Seen In The Gut Microbiota Market?

Leading businesses in the gut microbiota market are concentrating on creating innovative solutions, like orally administered fecal microbiota, to tackle a variety of gastrointestinal illnesses and conditions. This form of treatment involves taking a pill or capsule filled with beneficial bacteria from a healthy donor’s feces to restore equilibrium to the gut microbiome. In the example of Seres Therapeutics Inc., a US-based microbiome therapeutics platform company, they received FDA approval in April 2023 for Vowst, the first oral fecal microbiota product developed to prevent the recurrence of Clostridioides difficile infection (C. difficile) in adults aged 18 and over. The product, Vowst, is to be used post-antibacterial treatment for recurrent CDI. Such an approval indicates considerable progress in CDI treatment, offering a more user-friendly and accessible alternative to the conventional fecal microbiota transplants often delivered via colonoscopy or enema. The oral composition of this treatment could enhance treatment compliance and promote the wider acceptance of microbiome-based therapies in the medical field.

Which Companies Are Contributing Significantly To The Gut Microbiota Market Growth?

Major companies operating in the gut microbiota market are Danone S.A., DuPont de Nemours Inc., International Flavors & Fragrances Inc., Seres Therapeutics, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., Lifeway Foods Inc., BioGaia AB, Probi AB, Seed Health, Enterome, Vedanta Biosciences Inc., Evolve BioSystems Inc., Winclove Probiotics B.V., Kallyope Inc., Sun Genomics Inc., Synlogic Inc., OpenBiome, Codex Labs Corp.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/gut-microbiota-global-market-report

Which Region Is Leading Innovation In The Gut Microbiota Market?

North America was the largest region in the gut microbiota market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gut microbiota market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=23411&type=smp

Browse Through More Reports Similar to the Global Gut Microbiota Market 2025, By The Business Research Company

Animal Intestinal Health Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-intestinal-health-global-market-report

Disposable Intestinal Wash Bags Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/disposable-intestinal-wash-bags-global-market-report

Gastrointestinal Drug Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model